相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
A uniquely Egyptian epidemic
Mohammed Yahia
NATURE (2011)
Could antioxidants be the magic pill for cirrhosis-related complications? A pathophysiological appraisal
Stelios F. Assimakopoulos et al.
MEDICAL HYPOTHESES (2011)
Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate
Roberto Stasi et al.
ANNALS OF HEMATOLOGY (2010)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
ELTROMBOPAG IN CHRONIC LIVER DISEASE PATIENTS WITH THROMBOCYTOPENIA UNDERGOING AN ELECTIVE INVASIVE PROCEDURE: RESULTS FROM ELEVATE, A RANDOMISED CLINICAL TRIAL
N. Afdhal et al.
JOURNAL OF HEPATOLOGY (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Use of Thrombopoietic Agents for the Thrombocytopenia of Liver Disease
Hans L. Tillmann et al.
SEMINARS IN HEMATOLOGY (2010)
Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection
Elizabeth Y. Chiao et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
Romiplostim: chronic therapy for a chronic disease?
Adam Cuker et al.
BLOOD (2009)
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
David J. Kuter et al.
BLOOD (2009)
Thrombopoietin Agonists for the Treatment of Thrombocytopenia in Liver Disease and Hepatitis C
Geoffrey Dusheiko
CLINICS IN LIVER DISEASE (2009)
Thrombocytopenia associated with chronic liver disease
Nezam Afdhal et al.
JOURNAL OF HEPATOLOGY (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Viral-Associated Immune Thrombocytopenic Purpura
H. A. Liebman
Hematology-American Society of Hematology Education Program (2008)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura
Roberto Stasi et al.
BLOOD (2007)
An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura
Adrian Newland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt
MR Rao et al.
BMC INFECTIOUS DISEASES (2002)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
R Stasi et al.
BLOOD (2001)
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
C Frank et al.
LANCET (2000)
分享论文
